00:00Pharmaceutical giant Eli Lilly announced plans to acquire three vaccine developers
00:05in deals worth nearly $4 billion combined.
00:08The acquisitions include companies working on vaccines for shingles,
00:13Epstein-Barr virus and bacterial infections such as staph.
00:16The move marks a major expansion beyond Lilly's blockbuster obesity and diabetes drug business.
00:22Investors pushed Lilly shares slightly higher as analysts praised the company's strategy
00:27to diversify into infectious disease prevention.
00:31Experts say the deals reflect growing competition among drug makers
00:35to broaden their pipelines beyond weight loss medications.
Comments